| PROVECTIS HEALTHCARE AG - Docetaxel Provectis 160 mg/8 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 70427 | | 03 | | Docetaxel Provectis 160 mg/8 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01CD02 | | Docetaxel | | 12.01.2026 | | |
|
| Composition |
| docetaxelum 160 mg ut docetaxelum trihydricum, polysorbatum 80, acidum citricum, ethanolum anhydricum 3.16 g, ad solutionem pro 8 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Docetaxel | 160mg / 8ml |
| | BAG: Active Agent | Dose |
|---|
| Docetaxel | 160 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Citricum | | | Ethanol Anhydrate | 3.16g / 8ml | | Polysorbatum 80 | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 379.28 | 428.90 | A | SL | No |
|
